Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 114

Sort by

Sort Order Select

Journal Articles

Excellent Outcomes with Reduced Frequency of Vincristine and Dexamethasone Pulses in Children with National Cancer Institute (NCI) Standard-Risk B Acute Lymphoblastic Leukemia (SR B-ALL): A Report from Children's Oncology Group (COG) Study AALL0932

Anne Angiolillo, MD, Reuven J. Schore, MD, John Kairalla, Meenakshi Devidas, Karen R. Rabin, MD PhD, Patrick A. Zweidler-McKay, MD PhD, Michael J. Borowitz, MD PhD, Brent L Wood, MD PhD, Andrew J. Carroll, PhD, Nyla A. Heerema, PhD, Mary V. Relling, PharmD, Ashley Lane, Kelly Maloney, MD, Cindy Wang, MS, William L. Carroll, MD, Naomi Winick, MD, Elizabeth A. Raetz, MD, Mignon L. Loh, MD, Stephen P. Hunger, MD

Blood (2019) 134 (Supplement_1): 824.

https://doi.org/10.1182/blood-2019-123565

Published: 2019

Journal Articles

Retrospective Review of Appropriate Use of Antimicrobials and Anticoagulants in Patients Hospitalized for a Malignant Hematologic Condition

Louis-Bassett Porter, MD, Hanaa Shihadeh, Kim Dittus, MD PhD

Blood (2019) 134 (Supplement_1): 2116.

https://doi.org/10.1182/blood-2019-121534

Published: 2019

Journal Articles

A Multicenter Phase I Study Combining Venetoclax with Mini-Hyper-CVD in Older Adults with Untreated and Relapsed/Refractory Acute Lymphoblastic Leukemia

Nitin Jain, MD, Kristen E. Stevenson, MS, Eric S. Winer, MD, Jacqueline S Garcia, MD, Richard M. Stone, MD, Elias Jabbour, MD, Farhad Ravandi, MD, Jeremy M. Stewart, BA, Dean R Legg, BA, Hagop M. Kantarjian, MD, Donna S Neuberg, ScD, Anthony G. Letai, MD PhD, Marina Y Konopleva, MD PhD, Daniel J. DeAngelo, MD

Blood (2019) 134 (Supplement_1): 3867.

https://doi.org/10.1182/blood-2019-129988

Published: 2019

Journal Articles

Risk Factors of Acute Pancreatitis in Pediatric Acute Lymphoblastic Leukemia Patients: A Single-Center Experience

Soyoon MIN, MD, Hyery Kim, MD, Juhee Shin, Jin Kyung Suh, MD, Sung Han Kang, MD, Kyung-Nam Koh, MD, Ho Joon Im, MD, Jong Jin Seo, MD

Blood (2019) 134 (Supplement_1): 5077.

https://doi.org/10.1182/blood-2019-128236

Published: 2019

Journal Articles

Is It Time to Take MRD More Seriously? Relationship between MRD, Functional Cure and Life Expectancy Among Patients with Ph- B Cell Precursor ALL (BCP-ALL)

Qiujun Shao, Simran Tiwana, Nicholas Despiegel, Franziska Dirnberger

Blood (2019) 134 (Supplement_1): 5814.

https://doi.org/10.1182/blood-2019-126309

Published: 2019

Journal Articles

Major Deviations in the Delivery of Induction Chemotherapy Are Associated with an Increased Risk of Relapse in Acute Lymphoblastic Leukaemia: Results from UKALL2003

Rachael E Hough, MD, Amy A Kirkwood, Sujith Samarasinghe, Clare J Rowntree, MBBS, PhD FRCP, FRCPath, Nicholas John Goulden, MD PhD MRCPath, Ajay Vora

Blood (2019) 134 (Supplement_1): 2579.

https://doi.org/10.1182/blood-2019-127223

Published: 2019

Journal Articles

Minimal Residual Disease (MRD) Status after Induction Therapy Is a Strong Prognostic Factor in the Treatment of Adult Ph (-) Acute Lymphoblastic Leukemia (ALL): Results of a Prospective Study (ALL MRD2008 Study)

Koji Nagafuji, MD PhD, Toshihiro Miyamoto, MD PhD, Tetsuya Eto, MD PhD, Ryosuke Ogawa, MD PhD, Naoyuki Uchida, MD PhD, Ken Takase, MD, Noriaki Kawano, MD PhD, Tomoaki Fujisaki, MD PhD, Tomohiko Kamimura, MD PhD, Atsushi Wake, MD PhD, Hirokazu Okumura, MD PhD, Yasuhiko Miyazaki, MD PhD, Yasushi Takamatsu, MD PhD, Toshiro Kurokawa, MD PhD, Yuju Ohno, MD PhD, Shouhei Yokota, MP.Path, Koichi Akashi, MD PhD

Blood (2018) 132 (Supplement 1): 3970.

https://doi.org/10.1182/blood-2018-99-112848

Published: 2018

Journal Articles

Predictors of Outcomes in Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia at First Relapse in the Era of Tyrosine Kinase Inhibitors

Iman Aboudalle, MD, Hagop M. Kantarjian, MD, Nicholas J Short, MD, Marina Y. Konopleva, MD PhD, Nitin Jain, MD, Guillermo Garcia-Manero, MD, Rebecca E. Garris, MSc, Wei Qiao, PhD, Jorge E. Cortes, MD, Susan M. O'Brien, MD, Partow Kebriaei, MD, Tapan M. Kadia, MD, Elias J. Jabbour, MD, Farhad Ravandi, MD

Blood (2018) 132 (Supplement 1): 2659.

https://doi.org/10.1182/blood-2018-99-117579

Published: 2018

Journal Articles

Intensification of Oral Methotrexate Is Not Superior to Standard Methotrexate Dosing during Maintenance in Children with National Cancer Institute (NCI) Standard-Risk B Acute Lymphoblastic Leukemia (SR B-ALL): A Report from Children's Oncology Group (COG) Study AALL0932

Anne Angiolillo, MD, Reuven Schore, MD, Meenakshi Devidas, Xiaomin Lu, PhD, Karen R. Rabin, MD PhD, Patrick A. Zweidler-McKay, MDPhD, Michael Borowitz, MD PhD, Brent Wood, MDPhD, Andrew J. Carroll, III, PhD, Nyla A. Heerema, PhD, Cindy Wang, MS, Kelly Maloney, MD, Naomi Winick, MD, William L. Carroll, MD, Elizabeth A. Raetz, MD, Mignon L. Loh, MD, Stephen P. Hunger, MD

Blood (2017) 130 (Supplement 1): 140.

https://doi.org/10.1182/blood.V130.Suppl_1.140.140

Published: 2017

Journal Articles

Association of APEX1 and NUDT15 Polymorphisms with Mercaptopurine-Related Neutropenia in Pediatric Acute Lymphoblastic Leukemia

Hyery Kim, MD, Heewon Seo, Yoomi Park, ByungJoo Min, Myung-Eui Seo, Kyung Duk Park, MD, Hee Young Shin, MD, Jae Won Yoo, MD, Sung Han Kang, MD, Kyung Nam Koh, MD, Jong Jin Seo, MD, Ho Joon Im, MD, Ju Han Kim, MD, Hyoung Jin Kang, MD

Blood (2017) 130 (Supplement 1): 1320.

https://doi.org/10.1182/blood.V130.Suppl_1.1320.1320

Published: 2017

Journal Articles

Upregulated Cholesterol Biosynthesis Is a Biomarker for Isolated Central Nervous System Relapse in Acute Lymphoblastic Leukaemia

Antony Cousins, Elke Markert, Matilda Degn, PhD, Orianne Olivares, Yasar Mehmood Yousafzai, MBBS,PhD, Saeeda Bhatti, PhD, Pawel Herzyk, Alison M. Michie, PhD BSc, Kjeld Schmiegelow, MD DMSc, Eyal Gottlieb, PhD, Christina Halsey

Blood (2017) 130 (Supplement 1): 3992.

https://doi.org/10.1182/blood.V130.Suppl_1.3992.3992

Published: 2017

Journal Articles

Clonal Competition of Cancer Cells During Acute Lymphoblastic Leukemia Treatment

Humberto Contreras Trujillo, BS, Akil Merchant, MD, Rong Lu, PhD

Blood (2017) 130 (Supplement 1): 480.

https://doi.org/10.1182/blood.V130.Suppl_1.480.480

Published: 2017

Journal Articles

The Survival Impact of Lenalidomide Maintenance Chemotherapy in Multiple Myeloma Patients Treated with Autologous Stem Cell Transplant and Bortezomib-Based Induction: An Analysis of Real World Data

Hannah Cherniawsky, BSc, MD, Irwindeep Sandhu, MDFRCPC, Michael P. Chu, MD, Joanne D. Hewitt, NP, PhD, Ismail Ismail, Andrew Belch, Linda M. Pilarski, PhD, Tatiana Nikitina, PhD, Christopher P. Venner, MD

Blood (2017) 130 (Supplement 1): 3132.

https://doi.org/10.1182/blood.V130.Suppl_1.3132.3132

Published: 2017

Journal Articles

Hip Osteonecrosis in Pediatric Leukemia/Lymphoma Patients Treated with Glucocorticoids: Retrospective Analysis in a Single Institute

Yuki Arakawa, MD, Makiko Mori, MD, Masahiro Sugawa, MD, Jun Noguchi, MD, Ryota Kawakami, MD, Toshikazu Itabashi, MD, Masato Yanagi, MD, Kiyotaka Isobe, MD, Motohiro Kato, MD, Eiji Oguma, MD, Katsuaki Taira, MD, Katsuyoshi Koh, MD

Blood (2017) 130 (Supplement 1): 5014.

https://doi.org/10.1182/blood.V130.Suppl_1.5014.5014

Published: 2017

Journal Articles

Outcomes in Acute Lymphoblastic Leukemia at the University of Wisconsin: An Institutional Review

Luke D. Zurbriggen, MD, Michael Fallon, PharmD, Carrie Ketchem, MS, Ryan Mattison, MD

Blood (2017) 130 (Supplement 1): 5005.

https://doi.org/10.1182/blood.V130.Suppl_1.5005.5005

Published: 2017

Journal Articles

Validation of a Molecular Risk Score for Prognosis of Patients with Acute Promyelocytic Leukemia

Anna Hecht, MD, Seraphina Doll, Heidi Schaarschmidt, Daniel Nowak, MD, Verena Nowak, Julia Obländer, Christina Xanthopoulos, Eva Lengfelder, MD, Christoph Röllig, MD, Gerhard Ehninger, MD, Wolf-Karsten Hofmann, MD, Uwe Platzbecker

Blood (2016) 128 (22): 1668.

https://doi.org/10.1182/blood.V128.22.1668.1668

Published: 2016

Journal Articles

Frequency and Prognostic Significance of the Presence of Additional Cytogenetic Abnormalitions (ACA) to the Philadelphia (Ph) Chromosome in Young Adults with ACUTE Lymphoblastic Leukemia (ALL) Treated with the ALL Ph08 Trial from the Pethema Group

Blood (2016) 128 (22): 1602.

https://doi.org/10.1182/blood.V128.22.1602.1602

Published: 2016

Journal Articles

Comparison of Treatment Strategies in Patients over 60 Years with AML: Final Analysis of a Prospective Randomized German AML Intergroup Study

Blood (2016) 128 (22): 1066.

https://doi.org/10.1182/blood.V128.22.1066.1066

Published: 2016

Journal Articles

Prospective Phase II Study of Prophylactic Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

Thierry Guillaume, MD PhD, Ibrahim Yakoub-Agha, MD- PhD, Reza Tabrizi, MD, Cecile Borel, MD, Patrice Chevallier, MD PhD, Leonardo Magro, MD, Stéphane Vigouroux, MD, Pierre Peterlin, MD, Alice Garnier, MD, Marie-Thérèse Rubio, MD PhD, Anne Huynh, MD, Noel Milpied, MD PhD, Philippe Moreau, Mohamad Mohty, MD PhD

Blood (2016) 128 (22): 1162.

https://doi.org/10.1182/blood.V128.22.1162.1162

Published: 2016

Journal Articles

Mutational Landscape of Pediatric Acute Lymphoblastic Leukemia Relapsing after Allogeneic Stem Cell Transplantation

Jessica I Hoell, MD, Sebastian Ginzel, MSc, Cornelia Eckert, PhD, Michael Gombert, PhD, Ute Fischer, PhD, Martin Stanulla, MD, Martin Schrappe, MD PhD, Udo zur Stadt, PhD, Peter Bader, MD, Brigitte Strahm, MD, Julia Alten, Anja Moericke, MD, Gabriele Escherich, MD, Arend Stackelberg, MD, Christina Peters, MD, Arndt Borkhardt, MD, Roland Meisel, MD

Blood (2016) 128 (22): 601.

https://doi.org/10.1182/blood.V128.22.601.601

Published: 2016

NARROW

Excellent Outcomes with Reduced Frequency of Vincristine and Dexamethasone Pulses in Children with National Cancer Institute (NCI) Standard-Risk B Acute Lymphoblastic Leukemia (SR B-ALL): A Report from Children's Oncology Group (COG) Study AALL0932

Retrospective Review of Appropriate Use of Antimicrobials and Anticoagulants in Patients Hospitalized for a Malignant Hematologic Condition

A Multicenter Phase I Study Combining Venetoclax with Mini-Hyper-CVD in Older Adults with Untreated and Relapsed/Refractory Acute Lymphoblastic Leukemia

Risk Factors of Acute Pancreatitis in Pediatric Acute Lymphoblastic Leukemia Patients: A Single-Center Experience

Is It Time to Take MRD More Seriously? Relationship between MRD, Functional Cure and Life Expectancy Among Patients with Ph- B Cell Precursor ALL (BCP-ALL)

Major Deviations in the Delivery of Induction Chemotherapy Are Associated with an Increased Risk of Relapse in Acute Lymphoblastic Leukaemia: Results from UKALL2003

Minimal Residual Disease (MRD) Status after Induction Therapy Is a Strong Prognostic Factor in the Treatment of Adult Ph (-) Acute Lymphoblastic Leukemia (ALL): Results of a Prospective Study (ALL MRD2008 Study)

Predictors of Outcomes in Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia at First Relapse in the Era of Tyrosine Kinase Inhibitors

Intensification of Oral Methotrexate Is Not Superior to Standard Methotrexate Dosing during Maintenance in Children with National Cancer Institute (NCI) Standard-Risk B Acute Lymphoblastic Leukemia (SR B-ALL): A Report from Children's Oncology Group (COG) Study AALL0932

Association of APEX1 and NUDT15 Polymorphisms with Mercaptopurine-Related Neutropenia in Pediatric Acute Lymphoblastic Leukemia

Upregulated Cholesterol Biosynthesis Is a Biomarker for Isolated Central Nervous System Relapse in Acute Lymphoblastic Leukaemia

Clonal Competition of Cancer Cells During Acute Lymphoblastic Leukemia Treatment

The Survival Impact of Lenalidomide Maintenance Chemotherapy in Multiple Myeloma Patients Treated with Autologous Stem Cell Transplant and Bortezomib-Based Induction: An Analysis of Real World Data

Hip Osteonecrosis in Pediatric Leukemia/Lymphoma Patients Treated with Glucocorticoids: Retrospective Analysis in a Single Institute

Outcomes in Acute Lymphoblastic Leukemia at the University of Wisconsin: An Institutional Review

Validation of a Molecular Risk Score for Prognosis of Patients with Acute Promyelocytic Leukemia

Frequency and Prognostic Significance of the Presence of Additional Cytogenetic Abnormalitions (ACA) to the Philadelphia (Ph) Chromosome in Young Adults with ACUTE Lymphoblastic Leukemia (ALL) Treated with the ALL Ph08 Trial from the Pethema Group

Comparison of Treatment Strategies in Patients over 60 Years with AML: Final Analysis of a Prospective Randomized German AML Intergroup Study

Prospective Phase II Study of Prophylactic Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

Mutational Landscape of Pediatric Acute Lymphoblastic Leukemia Relapsing after Allogeneic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only